Use of human fat-derived mesenchymal stem cells in treatment of diseases in kidney and ocular fundus
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 微能生命科技集团有限公司
- Publication Date
- 2014-02-19
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The present invention generally relates to the use of mesenchymal stem cells. Specifically, the present invention relates to the use of human adipose-derived mesenchymal stem cells in kidney and / or fundus diseases. Background technique
[0002] Mesenchymal stem cells (MSCs) are widely used in the research of various diseases due to their ability of self-renewal and multilineage differentiation. Human adipose-derived MSCs (hAD-MSCs) are easy to obtain, expand and have the same Source MSCs have similar differentiation potential and have become the most popular seed cells in the field of regenerative medicine in recent years.
[0003] Acute kidney injury and the resulting renal fibrosis are common clinical pathological processes. Whether it is a variety of primary glomerular diseases, or secondary kidney diseases such as diabetic nephropathy and lupus nephritis, they are closely related to the degree of renal fibrosis. These diseases can cause apoptosi...